Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00472056
Status:
COMPLETED
Last Update Posted:
2016-03-15
First Post:
2007-05-09
Brief Title:
Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| Rituxan | View |
| Non-Hodgkins Lymphoma | View |
| Lymphoid Malignancies | View |
| Lymphoma | View |
| BEAM Chemotherapy | View |
| Carmustine | View |
| BCNU | View |
| BiCNU | View |
| Etoposide | View |
| VePesid | View |
| Cytarabine | View |
| Cytosar | View |
| DepoCyt | View |
| Cytosine arabinosine hydrochloride | View |
| Ara-C | View |
| Melphalan | View |
| Rituximab | View |